| David Vaughn, MD | |
|
1116 Millis Ave, Boonville, IN 47601-2242 | |
| (812) 897-4800 | |
| (812) 897-7375 |
| Full Name | David Vaughn |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1116 Millis Ave, Boonville, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831200237 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 01044912A (Indiana) | Primary |
| Entity Name | Emergency Professionals Of Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013951219 PECOS PAC ID: 4183604150 Enrollment ID: O20040721000612 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective therapies against Middle East Respiratory Syndrome (MERS).
A large multi-center clinical trial has found that a combination of antiviral medications can eradicate hepatitis C infection in more than 90 percent of patients with advanced liver disease. Known as the ASTRAL-4 trial, the study was co-led by investigators at Beth Israel Deaconess Medical Center and Intermountain Medical Center and published online Nov. 17 in The New England Journal of Medicine.
Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced financial results the third quarter ended September 30, 2009.
A landmark report by the London-based International Scientific Forum on Home Hygiene (IFH) on the so-called hygiene hypothesis finds "no justification" for claims that cleaning and hygiene contribute to an increase in allergies.
› Verified 4 days ago
| Entity Name | Daviess County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124231493 PECOS PAC ID: 1557271665 Enrollment ID: O20100420000663 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective therapies against Middle East Respiratory Syndrome (MERS).
A large multi-center clinical trial has found that a combination of antiviral medications can eradicate hepatitis C infection in more than 90 percent of patients with advanced liver disease. Known as the ASTRAL-4 trial, the study was co-led by investigators at Beth Israel Deaconess Medical Center and Intermountain Medical Center and published online Nov. 17 in The New England Journal of Medicine.
Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced financial results the third quarter ended September 30, 2009.
A landmark report by the London-based International Scientific Forum on Home Hygiene (IFH) on the so-called hygiene hypothesis finds "no justification" for claims that cleaning and hygiene contribute to an increase in allergies.
› Verified 4 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285103671 PECOS PAC ID: 6608056171 Enrollment ID: O20190214000611 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective therapies against Middle East Respiratory Syndrome (MERS).
A large multi-center clinical trial has found that a combination of antiviral medications can eradicate hepatitis C infection in more than 90 percent of patients with advanced liver disease. Known as the ASTRAL-4 trial, the study was co-led by investigators at Beth Israel Deaconess Medical Center and Intermountain Medical Center and published online Nov. 17 in The New England Journal of Medicine.
Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced financial results the third quarter ended September 30, 2009.
A landmark report by the London-based International Scientific Forum on Home Hygiene (IFH) on the so-called hygiene hypothesis finds "no justification" for claims that cleaning and hygiene contribute to an increase in allergies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Vaughn, MD 6422 Venice Dr, Newburgh, IN 47630-6902 Ph: (812) 490-0454 | David Vaughn, MD 1116 Millis Ave, Boonville, IN 47601-2242 Ph: (812) 897-4800 |
News Archive
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective therapies against Middle East Respiratory Syndrome (MERS).
A large multi-center clinical trial has found that a combination of antiviral medications can eradicate hepatitis C infection in more than 90 percent of patients with advanced liver disease. Known as the ASTRAL-4 trial, the study was co-led by investigators at Beth Israel Deaconess Medical Center and Intermountain Medical Center and published online Nov. 17 in The New England Journal of Medicine.
Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced financial results the third quarter ended September 30, 2009.
A landmark report by the London-based International Scientific Forum on Home Hygiene (IFH) on the so-called hygiene hypothesis finds "no justification" for claims that cleaning and hygiene contribute to an increase in allergies.
› Verified 4 days ago
Rick Yeager, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1116 Millis Ave, Boonville, IN 47601 Phone: 812-897-4800 Fax: 812-897-7375 | |
Josel V Mijares, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1116 Millis Ave, Boonville, IN 47601 Phone: 812-897-7383 |